2019
DOI: 10.1097/paf.0000000000000484
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers of Cerebral Damage in Fatal Hypothermia

Abstract: Biomarkers of cerebral damage in fatal hypothermia: preliminary results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 29 publications
1
5
0
Order By: Relevance
“…Patients with hypothermia show progressively installed neurological manifestations, which can progress to coma and death [1]. They most often appear when the brain temperature progressively decreases, considering that a 1 • C drop in temperature is associated with a 6-8% reduction in cerebral metabolism, similar to the results obtained in an experimental model [21].…”
Section: Discussionsupporting
confidence: 67%
See 3 more Smart Citations
“…Patients with hypothermia show progressively installed neurological manifestations, which can progress to coma and death [1]. They most often appear when the brain temperature progressively decreases, considering that a 1 • C drop in temperature is associated with a 6-8% reduction in cerebral metabolism, similar to the results obtained in an experimental model [21].…”
Section: Discussionsupporting
confidence: 67%
“…Patients with hypothermia show progressively installed neurological manifestations, which can progress to coma and death [1]. They most often appear when the brain…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…TNF- α , IL-1, TGF- β 1, FGF-2, and VEGF-2 induce endocan expression in vitro , IFN- γ inhibits TNF- α induced upregulation of endocan ( Scherpereel et al, 2003 ). Endocan is associated with neuroinflamation in highly vascularized tumors in meningiomas, gliomas and lung cancer ( Maurage et al, 2009 ) and with new blood vessel development in glioma ( Maurage et al, 2009 ), pituitary adenoma, renal cell carcinoma, pediatric brain injury ( Lele et al, 2019 ) and is a biomarker of cerebral damage ( Morleo et al, 2019 ). Endocan expression is upregulated in human cytomegaloviral infection which increases glioma development in brain tissues ( Scherpereel et al, 2003 ; Xing et al, 2016 ) leading to its suggestion as a therapeutic target in glioma ( Atukeren et al, 2016 ).…”
Section: The Small Neural Proteoglycansmentioning
confidence: 99%